| Autor: |
Brilla, Christian G., Krämer, Bernhard, Hoffmeister, Hans M., Müller-Schauenburg, Wolfgang, Risler, Teut, Seipel, Ludger |
| Zdroj: |
Cardiovascular Drugs and Therapy; March 1989, Vol. 3 Issue: 2 p211-218, 8p |
| Abstrakt: |
Summary In a 3-month prospective, single-blind, controlled trial, 38 patients in New York Heart Association functional class III–IV were assigned to group E (n=19): enalapril 5 mg/day in addition to the previous therapy with digitalis and diuretics, or group C (n=19): continuation of the previous therapy. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink